Program details
-
Diabetes complications 1
Crossing the boundaries of diabetic retinopathy: from pathophysiological insight to integrated care (cross-specialty with the Korean ophthalmological society)
Chair(s): Sang Ah Chang, Chan Yun Kim
Friday 26 September, 15:00~16:20
Room 3
(Walker hall 1, 1F) - As diabetes continues to rise worldwide, its microvascular complications -especially diabetic retinopathy (DR)- pose an increasing challenge to comprehensive care. DR is now recognized as more than a localized eye disease; it reflects systemic metabolic dysfunction and calls for multidisciplinary collaboration. This cross-specialty session explores the latest insights into DR pathophysiology, advances in diagnostic imaging, and the systemic management strategies that shape retinal outcomes. Bridging basic science and clinical practice, we aim to illuminate new pathways for integrated care in diabetes.
-
-
S10-L1
Junyeop LeeUniversity of Ulsan, Department of Ophthalmology, Korea - Beyond the vessels: emerging pathways in diabetic retinopathy
-
S10-L2
Sang Jun ParkSeoul National University, Department of Ophthalmology, Korea - Revolutionizing DR detection and care: patient-centric digital-empowered platform
-
S10-L3
Seung Min ChungYeungnam University, Korea - Managing diabetes for the eye: systemic diabetes management and its retinal implications
- Panel discussion
-
-
S10-P1
Kyung Ae LeeJeonbuk National University, Korea -
S10-P2
Jin-woo JeongWonkwang University, Korea -
S10-P3
Hae Kyung KimYonsei University, Korea
-
-
-
Diabetes complications 2
Precision medicine of diabetic kidney disease (cross-specialty with the Korean society of nephrology)
Chair(s): Dae Ho Lee, Hyeong Cheon Park
Friday 26 September, 16:30-17:50
Room 3
(Walker hall 1, 1F) - Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. It is a multifactorial disease. The pathophysiology of DKD and the response to treatment can vary significantly among individuals. As technology advances, we can adopt a more personalized approach to managing DKD. This session will discuss the significance of precision medicine, recent advancements, and effective therapeutic strategies for treatment.
-
-
S09-L1
Petter BjornstadUW Medicine Diabetes Institute, USA - Lessons from human kidney tissue in diabetes
-
S09-L2
David CherneyUniversity of Toronto, Canada - Therapeutic strategies for DKD
-
S09-L3
Mi Kyung KimKeimyung University, Korea - Not all diabetic kidney disease is diabetic nephropathy: why kidney biopsy is often crucial
-
-
Diabetes complications 3
Diabetes and the brain: emerging links, therapies, and future directions (cross-specialty with the Korean Neurological Association)
Chair(s): Kunwoo Park, Jungmin Lee
Saturday 27 September, 08:40~10:00
Room 3
(Walker hall 1, 1F) - This session will explore the shared pathophysiological mechanisms linking diabetes and brain disorders, focusing on insulin resistance, vascular dysfunction, and chronic inflammation. To enhance understanding, neuroimaging studies will be presented to illustrate structural and functional brain changes observed in individuals with diabetes. In addition, the session will highlight the emerging role of antidiabetic agents—particularly GLP-1 receptor agonists—in preserving cognitive function and potentially slowing the progression of neurodegenerative diseases. By integrating clinical evidence, imaging findings, and pharmacological strategies, this session will offer a comprehensive perspective on diabetes management as a critical approach to protecting brain health.
-
-
S11-L1
Byoung Seok YeYonsei University, Department of Neurology, Korea - Diabetes and dementia with a focus on Alzheimer's disease and lewy body dementia
-
S11-L2
Seong Ho JeongDepartment of Neurology, Yonsei University, Korea - Unraveling the diabetes-Parkinson's connection with shared pathways and therapeutic insights from antidiabetic agent
-
S11-L3
Paul EdisonImperial College London, UK - The diabetic brain on imaging
-
S11-L4
Jin Hwa KimChosun University, Korea - From glycemia to cognitive rescue: a new paradigm for treating diabetes and neurodegeneration with GLP-1RA
-
Korean Diabetes Association-
- (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
- Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
- Business Registration Number: 106-82-31108 | Name of Representative: Bong-Soo Cha
- Congress Secretariat (Planbear)
-
- #1108, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
- Tel. +82-2-6953-0582 E-mail: icdm@diabetes.or.kr
copyright© By Korean Diabetes Association.
All rights reserved.
Business Registration Number: 106-82-31108
Name of Representative : Bong-Soo Cha
